This thesis is submitted as a PhD by Portfolio of Publications. It represents an integrated examination of the BCR-ABL oncogene as a precise indicator of treatment response, drug resistance and relapse in patients with chronic myeloid leukaemia (CML). / Thesis (PhDBiomedicalScience)--University of South Australia, 2005.
Identifer | oai:union.ndltd.org:ADTP/267333 |
Creators | Branford, Susan. |
Source Sets | Australiasian Digital Theses Program |
Language | English |
Detected Language | English |
Rights | copyright under review |
Page generated in 0.0021 seconds